[go: up one dir, main page]

DK1173436T3 - Thiazolidindionderivat og anvendelse deraf som antidiabetikum - Google Patents

Thiazolidindionderivat og anvendelse deraf som antidiabetikum

Info

Publication number
DK1173436T3
DK1173436T3 DK00920893T DK00920893T DK1173436T3 DK 1173436 T3 DK1173436 T3 DK 1173436T3 DK 00920893 T DK00920893 T DK 00920893T DK 00920893 T DK00920893 T DK 00920893T DK 1173436 T3 DK1173436 T3 DK 1173436T3
Authority
DK
Denmark
Prior art keywords
diabetic
thiazolidinedione derivative
thiazolidinedione
derivative
Prior art date
Application number
DK00920893T
Other languages
English (en)
Inventor
Paul David James Smit Blackler
Robert Gordon Giles
Michael John Sasse
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of DK1173436T3 publication Critical patent/DK1173436T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
DK00920893T 1999-04-20 2000-04-19 Thiazolidindionderivat og anvendelse deraf som antidiabetikum DK1173436T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9909041.7A GB9909041D0 (en) 1999-04-20 1999-04-20 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
DK1173436T3 true DK1173436T3 (da) 2004-09-27

Family

ID=10851901

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00920893T DK1173436T3 (da) 1999-04-20 2000-04-19 Thiazolidindionderivat og anvendelse deraf som antidiabetikum

Country Status (42)

Country Link
EP (2) EP1411055A1 (da)
JP (2) JP4283449B2 (da)
KR (1) KR100601244B1 (da)
CN (2) CN101134756A (da)
AP (1) AP1562A (da)
AR (2) AR023566A1 (da)
AT (1) ATE268770T1 (da)
AU (2) AU4130900A (da)
BG (1) BG65864B1 (da)
BR (1) BR0009897A (da)
CA (1) CA2382036A1 (da)
CO (1) CO5170422A1 (da)
CZ (1) CZ300653B6 (da)
DE (1) DE60011419T2 (da)
DK (1) DK1173436T3 (da)
DZ (1) DZ3162A1 (da)
EA (1) EA004232B1 (da)
EG (1) EG24063A (da)
ES (1) ES2218146T3 (da)
GB (1) GB9909041D0 (da)
HK (1) HK1045151B (da)
HR (1) HRP20010770B1 (da)
HU (1) HUP0200865A3 (da)
IL (1) IL146078A0 (da)
MA (1) MA26783A1 (da)
MX (1) MXPA01010696A (da)
MY (1) MY126034A (da)
NO (1) NO320609B1 (da)
NZ (1) NZ515166A (da)
OA (1) OA11866A (da)
PE (1) PE20010050A1 (da)
PL (1) PL351135A1 (da)
PT (1) PT1173436E (da)
RS (1) RS50136B (da)
SI (1) SI1173436T1 (da)
SK (1) SK284991B6 (da)
TR (1) TR200103040T2 (da)
TW (1) TWI277616B (da)
UA (1) UA71615C2 (da)
UY (1) UY26112A1 (da)
WO (1) WO2000063205A2 (da)
ZA (1) ZA200108720B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9909041D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical
GB0006133D0 (en) 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical
GB0014005D0 (en) * 2000-06-08 2000-08-02 Smithkline Beecham Plc Novel pharmaceutical
KR20040062963A (ko) * 2001-11-21 2004-07-09 스미스클라인비이참피이엘시이 5-(4-(2-(n-메틸-n-(2-피리딜)아미노)에톡시)벤질)티아졸리딘-2,4-디온 벤젠술포네이트, 그의 제조 방법, 그의다형체 ⅰ, ⅱ 및 ⅲ, 및 제약상 활성 성분으로서의 그의용도
GB0129872D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
CZ296468B6 (cs) * 2004-06-10 2006-03-15 Zentiva, A. S. Sul kyseliny fosforecné s 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidin-2,4-dionema zpusob její prípravy
CZ296472B6 (cs) * 2004-07-27 2006-03-15 Zentiva, A. S Sul kyseliny stavelové s 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidin-2,4-dionu azpusob její prípravy a její pouzití
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
EP1842850A1 (en) * 2006-03-23 2007-10-10 Sandoz AG Rosiglitazone hydrochloride hemihydrate

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0306228B1 (en) * 1987-09-04 1999-11-17 Beecham Group Plc Substituted thiazolidinedione derivatives
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9726563D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726566D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726568D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9909041D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
JP4283449B2 (ja) 2009-06-24
EP1411055A1 (en) 2004-04-21
SI1173436T1 (en) 2004-12-31
RS50136B (sr) 2009-03-25
MA26783A1 (fr) 2004-12-20
CZ300653B6 (cs) 2009-07-08
EG24063A (en) 2008-05-08
UA71615C2 (uk) 2004-12-15
BR0009897A (pt) 2002-04-16
ZA200108720B (en) 2002-11-28
AR023562A1 (es) 2002-09-04
SK14902001A3 (sk) 2002-02-05
NZ515166A (en) 2004-02-27
NO20015104L (no) 2001-12-19
HRP20010770A2 (en) 2002-10-31
AU2755202A (en) 2002-05-16
IL146078A0 (en) 2002-07-25
AU4130900A (en) 2000-11-02
AU765911B2 (en) 2003-10-02
BG106112A (bg) 2002-05-31
HUP0200865A2 (en) 2002-08-28
HK1045151B (en) 2005-03-18
OA11866A (en) 2006-03-02
DE60011419D1 (de) 2004-07-15
ES2218146T3 (es) 2004-11-16
HRP20010770B1 (en) 2005-06-30
CZ20013759A3 (cs) 2002-05-15
EP1173436A2 (en) 2002-01-23
CO5170422A1 (es) 2002-06-27
EA004232B1 (ru) 2004-02-26
MXPA01010696A (es) 2002-06-04
JP2009143954A (ja) 2009-07-02
GB9909041D0 (en) 1999-06-16
YU81501A (sh) 2004-07-15
SK284991B6 (sk) 2006-04-06
BG65864B1 (bg) 2010-03-31
CN1327447A (zh) 2001-12-19
EA200101101A1 (ru) 2002-04-25
HUP0200865A3 (en) 2005-04-28
PT1173436E (pt) 2004-10-29
DE60011419T2 (de) 2005-06-16
PE20010050A1 (es) 2001-03-10
WO2000063205A3 (en) 2001-01-25
TR200103040T2 (tr) 2002-04-22
HK1045151A1 (en) 2002-11-15
ATE268770T1 (de) 2004-06-15
NO20015104D0 (no) 2001-10-19
AP1562A (en) 2006-02-01
JP2002542242A (ja) 2002-12-10
PL351135A1 (en) 2003-03-24
TWI277616B (en) 2007-04-01
KR20010110791A (ko) 2001-12-13
NO320609B1 (no) 2005-12-27
AP2001002331A0 (en) 2000-04-19
AR023566A1 (es) 2002-09-04
EP1173436B1 (en) 2004-06-09
CA2382036A1 (en) 2000-10-26
CN101134756A (zh) 2008-03-05
DZ3162A1 (fr) 2000-10-26
KR100601244B1 (ko) 2006-07-19
MY126034A (en) 2006-09-29
UY26112A1 (es) 2000-12-29
WO2000063205A2 (en) 2000-10-26

Similar Documents

Publication Publication Date Title
IS6385A (is) Ný notkun og nýjar N-asabísýkló-amíð afleiður
DK1216247T3 (da) Imidazoimidazoler og triazoler som anti-inflammatoriske midler
NO20025978L (no) Benzotiazol-derivater
DK1329456T3 (da) Glucopyranosyloxybenzylbenzenderivater og medicinske sammensætninger indeholdende samme
NO20022086D0 (no) Antidiabetisk formulering og fremgangsmåte
NO20020683L (no) Arylmetyl karbonylamino tiazolderivater og deres anvendelse som antitumormidler
NO20050077L (no) Substituerte heterocykliske derivater som er anvendelige som antidiabetes- og antiovervektsmidler
DK1244641T3 (da) Thiazolylamid-derivater
NO20032842L (no) Karbazolderivater og deres anvendelse som neuropeptid Y5- reseptor-ligander
ATE391505T1 (de) Benzothiazole derivative
NO20021253L (no) Kinolylpropylpiperidinderivater og deres anvendelse som antibakterielle midler
DK1173434T3 (da) Thiazolidindionderivat og dets anvendelse som antidiabetisk middel
DE60032898D1 (de) Arylthiazolidindion- und aryloxazolidinderivate
IS2841B (is) Samstæða hluta og lyfjasamsetningar
NO20001905L (no) (Poly)tiaalkynforbindelser og deres derivater, preparater omfattende disse og deres anvendelse
NO20020155D0 (no) Aminotiazolderivater og deres anvendelse som CRF reseptorligander
IL146115A0 (en) Thiazolidinedione derivative and its use as antidiabetic
NO20025968L (no) Pyridin-2-yl-aminoalkylkarbonylglycyl-<beta>-alanin og derivater derav
DK1173436T3 (da) Thiazolidindionderivat og anvendelse deraf som antidiabetikum
DK1231211T3 (da) Thiazolidindion-derivater som antidiabetika
ATE330603T1 (de) Benzothiazolderivaten
DK1173437T3 (da) Thiazolidinindionderivat og dets anvendelse som antidiabetisk middel
DK1392670T3 (da) Substituerede C-furan-2-yl-methylamin- og C-thiophen-2-yl-methylamin-derivater
NO20035652D0 (no) Tiaziner og tiazoler som materialbeskyttelsesmidler
NO20031434D0 (no) Tiazolidindionderivater og deres anvendelse som antidiabetiske midler